Padilla v. Mead Johnson & Company,LLC

CourtDistrict Court, N.D. Illinois
DecidedOctober 12, 2022
Docket1:22-cv-02720
StatusUnknown

This text of Padilla v. Mead Johnson & Company,LLC (Padilla v. Mead Johnson & Company,LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Padilla v. Mead Johnson & Company,LLC, (N.D. Ill. 2022).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

IN RE: ABBOTT LABORATORIES, et al., ) PRETERM INFANT NUTRITION PRODUCTS ) MDL No. 3026 LIABILITY LITIGATION ) ) Master Docket No. 22 C 71 This Document Relates to: ) Removed Pennsylvania Cases1 ) Judge Rebecca R. Pallmeyer )

MEMORANDUM OPINION AND ORDER Plaintiffs have moved for remand of some twenty-nine cases pending before this court as part of this multidistrict litigation. Each case was filed in Pennsylvania state court, removed by Defendant Abbott Laboratories on the basis of diversity jurisdiction, and transferred to this district by the Judicial Panel on Multidistrict Litigation. Some Plaintiffs are Pennsylvania citizens, while others are not, but each Plaintiff asserts some claims against at least one hospital with Pennsylvania citizenship. Citing the presence of these “Hospital Defendants,” Plaintiffs contend that each case must be remanded to state court either because (1) complete diversity is absent, see 28 U.S.C.

1 This opinion resolves motions to remand in twenty-nine cases that were removed from Pennsylvania state court before being transferred to this district and consolidated in the MDL: Abdullah v. Mead Johnson & Co., No. 22 C 2511 [22]; Drayton v. Mead Johnson & Co., No. 22 C 2513 [22]; Stills v. Mead Johnson & Co., No. 22 C 2515 [23]; Carter v. Mead Johnson & Co., No. 22 C 2516 [19]; Taylor v. Mead Johnson & Co., No. 22 C 2517 [19]; Weiger v. Mead Johnson & Co., No. 22 C 2518 [21]; Wieger v. Mead Johnson & Co., No. 22 C 2519 [22]; Henderson v. Mead Johnson & Co., No. 22 C 2611 [24]; Hines v. Mead Johnson & Co., No. 22 C 2612 [23]; Johnson v. Mead Johnson & Co., No. 22 C 2613 [23]; McMillian v. Mead Johnson & Co., No. 22 C 2614 [24]; Moment v. Mead Johnson & Co., No. 22 C 2615 [24]; Walker-Savage v. Mead Johnson & Co., No. 22 C 2616 [19]; Sanders v. Mead Johnson & Co., No. 22 C 2617 [23]; Short v. Mead Johnson & Co., No. 22 C 2618 [24]; Whitfield v. Mead Johnson & Co., No. 22 C 2619 [23]; Thomas v. Mead Johnson & Co., No. 22 C 2620 [23]; Williams v. Mead Johnson & Co., No. 22 C 2621 [23]; Witherspoon v. Mead Johnson & Co., No. 22 C 2623 [22]; Goodmond v. Mead Johnson & Co., No. 22 C 2712 [16]; Goodmond v. Mead Johnson & Co., No. 22 C 2713 [16]; Gray v. Mead Johnson & Co., No. 22 C 2714 [17]; Kajuffa v. Mead Johnson & Co., No. 22 C 2716 [19]; Mays v. Mead Johnson & Co., No. 22 C 2719 [17]; Padilla v. Mead Johnson & Co., No. 22 C 2720 [18]; Parker v. Mead Johnson & Co., No. 22 C 2760 [19]; Ross v. Mead Johnson & Co., No. 22 C 2761 [19]; Wiggins v. Mead Johnson & Co., No. 22 C 2762 [19]; Watson v. Mead Johnson & Co., No. 22 C 2763 [16]. § 1332(a), or (2) the forum-defendant rule prohibits removal, see 28 U.S.C. § 1441(b)(2). Defendant Abbott, which is not a citizen of Pennsylvania, concedes that the Hospital Defendants appear, at first blush, to either preclude diversity jurisdiction or trigger the forum-defendant rule in all twenty-nine cases. Abbott nevertheless opposes the remand motions. In its view, Plaintiffs cannot possibly succeed on their claims against the Hospital Defendants—and joined them solely to avoid federal court through jurisdictional gamesmanship. If this theory of “fraudulent joinder” were correct, the court would ignore the citizenship of the Hospital Defendants and keep these cases in federal court. The operative question, to verify Abbott’s theory, is whether Plaintiffs have a reasonable possibility of prevailing on their claims against the Hospital Defendants in state court. The court issued a preliminary ruling on Plaintiffs’ motions in August. In re Abbott Lab’ys, No. 22 C 71, 2022 WL 3586150 (N.D. Ill. Aug. 22, 2022) [191]. In that opinion, the court rejected Abbott’s fraudulent-joinder theory as to the substance of Plaintiffs’ tort claims against the Hospital Defendants, id. at *7–9,2 but noted a separate reason for concern about the viability of Plaintiffs’ claims: Plaintiffs’ failure to file “certificates of merit” (COMs) in accordance with Pennsylvania’s rules of civil procedure, id. at *9–11. The court invited the parties to file supplemental briefing on the COM issue. After reviewing the parties’ supplemental briefing, the court now concludes that Abbott has not established that Plaintiffs lack any reasonably possibility of prevailing on their claims against the Hospital Defendants. Plaintiffs’ motions to remand are granted.

2 After that opinion issued, Hospital Defendants filed answers in five of the 29 cases. See Goodmond v. Mead Johnson & Co., No. 22 C 2712 [21]; Goodmond v. Mead Johnson & Co., No. 22 C 2713 [24]; Gray v. Mead Johnson & Co., No. 22 C 2714 [23]; Mays v. Mead Johnson & Co., No. 22 C 2719 [23]; Watson v. Mead Johnson & Co., No. 22 C 2763 [22]. That the parties are at issue confirms the court’s substantive conclusion, at least for those five cases. DISCUSSION3 Plaintiffs assert two Pennsylvania state-law claims against the Hospital Defendants: negligent failure to warn and “negligent corporate liability of healthcare provider” (i.e., corporate negligence). (See, e.g., Compl. ¶¶ 108–42, Parker v. Mead Johnson & Co., No. 22 C 2760 [1- 1].)4 In the parties’ previous briefing, Abbott argued that Plaintiffs had no reasonable possibility of prevailing on these claims because Plaintiffs had not alleged that the Hospital Defendants breached any duties that Pennsylvania law imposes on hospitals. The court disagreed, at least with respect to Plaintiffs’ corporate-negligence claim. It concluded that “Abbott has not met its heavy burden of establishing there is no reasonable possibility of success for Plaintiffs’ claim that Defendant Hospitals should have implemented policies or oversight to restrict the use of cow’s- milk-based products for premature babies.”5 In re Abbott Lab’ys, 2022 WL 3586150, at *8. Despite its conclusion that Plaintiffs had stated theoretically viable claims against the Hospital Defendants, the court could not determine, on the existing record, whether Plaintiffs had a reasonable possibility of prevailing. The court’s hesitation related to Pennsylvania’s requirement that certain types of claims be supported by a document known as a “certificate of merit” (COM). The court speculated that, even if Plaintiffs had stated theoretically viable claims against the Hospital Defendants, their failure to file COMs might nevertheless prevent them from prevailing in state court. The parties had “provided limited information about Plaintiffs’ compliance” with the COM requirement—or about the relevance of such noncompliance to the

3 For relevant background information, and for elaboration of the fraudulent-joinder standard, the court refers readers to its prior opinion on these motions. See In re Abbott Lab’ys, 2022 WL 3586150, at *1–4.

4 In resolving these motions, the court treats the complaint in Parker as representative of the complaints in the other twenty-eight cases. See In re Abbott Lab’ys, 2022 WL 3586150, at *1 n.2.

5 Having arrived at this conclusion about Plaintiffs’ corporate-negligence claim, the court declined to “determine conclusively whether Plaintiffs can proceed against Defendant Hospitals on a failure-to-warn theory.” See In re Abbott Lab’ys, 2022 WL 3586150, at *8. fraudulent-joinder analysis. Id. at *10. The court requested supplemental briefing to help fill those gaps. (See Abbott’s Omnibus Supp. Mem. of Law in Opp. to Pls.’ Mots. to Remand to Penn. [208] (hereinafter “Abbott’s Supp. Mem.”); Pls.’ Supp. Br. in Supp. of Their Mots to Remand [209] (hereinafter “Pls.’ Supp. Mem.”).) Pennsylvania Rule of Civil Procedure 1042.3 provides that “[i]n any action based upon an allegation that a licensed professional deviated from an acceptable professional standard,” the plaintiff must file a COM within sixty days after the filing of the complaint.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Womer v. Hilliker
908 A.2d 269 (Supreme Court of Pennsylvania, 2006)
Stroud v. Abington Memorial Hospital
546 F. Supp. 2d 238 (E.D. Pennsylvania, 2008)
Moore v. JOHN A. LUCHSINGER, PC
862 A.2d 631 (Superior Court of Pennsylvania, 2004)
James Perez v. Staples Contract & Commercial
31 F.4th 560 (Seventh Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Padilla v. Mead Johnson & Company,LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/padilla-v-mead-johnson-companyllc-ilnd-2022.